Literature DB >> 11095950

Extracellular N-domain alone can mediate specific heterophilic adhesion between members of the carcinoembryonic antigen family, CEACAM6 and CEACAM8.

S Oikawa1, M Sugiyama, M Kuroki, M Kuroki, H Nakazato.   

Abstract

The domain(s) responsible for the specific heterophilic adhesion between two members of the carcinoembryonic antigen (CEA) family, CEACAM6 and CEACAM8, both of which with three extracellular domains, were investigated using Chinese hamster ovary (CHO) transfectants expressing chimeric antigens. Using a chimeric antigen in which the N-domain, a sole extracellular domain, of CEACAM3 was substituted with that of CEACAM6, it was shown that the N-domain of CEACAM6 alone was able to mediate specific adhesion to CEACAM8. Furthermore, the chimeric antigen was shown to bind significantly to chimeric CEA whose N-domain was substituted with that of CEACAM8, but not to unsubstituted CEA. These results demonstrate that the N-domain alone is sufficient and other domains of CEACAM6 or CEACAM8 are not required for this specific binding. We therefore propose a model of heterophilic interaction between the N-domains, which is distinct from that of CEA-CEA homophilic binding. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095950     DOI: 10.1006/bbrc.2000.3858

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Therapeutic antibodies for the treatment of pancreatic cancer.

Authors:  Patrick Chames; Brigitte Kerfelec; Daniel Baty
Journal:  ScientificWorldJournal       Date:  2010-06-15

2.  Molecular targeting of CEACAM6 using antibody probes of different sizes.

Authors:  Gang Niu; Yanal M Murad; Haokao Gao; Shuo Hu; Ning Guo; Orit Jacobson; Thanh-Dung Nguyen; Jianbing Zhang; Xiaoyuan Chen
Journal:  J Control Release       Date:  2012-05-05       Impact factor: 9.776

3.  Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.

Authors:  Christopher J Riley; Kevin P Engelhardt; Jose W Saldanha; Wenqing Qi; Laurence S Cooke; Yingting Zhu; Satya T Narayan; Kishore Shakalya; Kimiko Della Croce; Ivan G Georgiev; Raymond B Nagle; Harinder Garewal; Daniel D Von Hoff; Daruka Mahadevan
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

4.  Binding of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation.

Authors:  Natalia Korotkova; Yi Yang; Isolde Le Trong; Ernesto Cota; Borries Demeler; Jan Marchant; Wendy E Thomas; Ronald E Stenkamp; Steve L Moseley; Steve Matthews
Journal:  Mol Microbiol       Date:  2007-12-11       Impact factor: 3.501

5.  Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.

Authors:  Seung-Myoung Son; Jieun Yun; Sung-Hoon Lee; Hye Sook Han; Young Hyun Lim; Chang Gok Woo; Ho-Chang Lee; Hyung Geun Song; Young-Mi Gu; Hyun-Jun Lee; Ok-Jun Lee
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

6.  Synthetic peptides from the N-domains of CEACAMs activate neutrophils.

Authors:  K M Skubitz; K D Campbell; A P Skubitz
Journal:  J Pept Res       Date:  2001-12

7.  Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis.

Authors:  Miguel Burgos; Iván Cavero-Redondo; Celia Álvarez-Bueno; Eva María Galán-Moya; Atanasio Pandiella; Eitan Amir; Alberto Ocaña
Journal:  Ther Adv Med Oncol       Date:  2022-01-19       Impact factor: 8.168

8.  Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens.

Authors:  Tim Schmitter; Franziska Agerer; Lisa Peterson; Petra Munzner; Christof R Hauck
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.